Non-Hodgkin lymphoma

Results: 51



#Item
31Susceptibility Genes and Molecular Markers:  Cervical Cancer and Non-Hodgkin Lymphoma

Susceptibility Genes and Molecular Markers: Cervical Cancer and Non-Hodgkin Lymphoma

Add to Reading List

Source URL: dels.nas.edu

Language: English - Date: 2014-12-09 12:25:41
32小児医科学分野(小児科学) 1.論文 (1)原著 1)Fujita N, Mori T, Mitsui T, Inada H, Horibe K, Tsurusawa M:Relapsed or Primary Refractory Childhood B-cell non-Hodgkin lymphoma and mature B-ce

小児医科学分野(小児科学) 1.論文 (1)原著 1)Fujita N, Mori T, Mitsui T, Inada H, Horibe K, Tsurusawa M:Relapsed or Primary Refractory Childhood B-cell non-Hodgkin lymphoma and mature B-ce

Add to Reading List

Source URL: www.id.yamagata-u.ac.jp

Language: English - Date: 2009-08-10 23:14:21
33The IARC Monographs Workshops: Tumour Concordance between Humans and Experimental Animals and Mechanisms Involved in Human Carcinogenesis  R. Baan, Y. Grosse, P. Lajoie, B. Lauby-Secretan, F. El Ghissassi, V. Bouvard, L.

The IARC Monographs Workshops: Tumour Concordance between Humans and Experimental Animals and Mechanisms Involved in Human Carcinogenesis R. Baan, Y. Grosse, P. Lajoie, B. Lauby-Secretan, F. El Ghissassi, V. Bouvard, L.

Add to Reading List

Source URL: monographs.iarc.fr

Language: English - Date: 2014-01-20 09:57:45
34Phase I Study of the Administration of EBV CTLs Expressing CD30 Chimeric Receptors (CAR.CD30) for Relapsed  CD30+ Hodgkin Lymphoma and  CD30+ Non-Hodgkin Lymphoma

Phase I Study of the Administration of EBV CTLs Expressing CD30 Chimeric Receptors (CAR.CD30) for Relapsed CD30+ Hodgkin Lymphoma and CD30+ Non-Hodgkin Lymphoma

Add to Reading List

Source URL: osp.od.nih.gov

Language: English - Date: 2013-12-31 14:00:44
35Oncologic Drugs Advisory Committee Meeting Briefing Document  Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or

Oncologic Drugs Advisory Committee Meeting Briefing Document Pixantrone dimaleate (BBR[removed]Injection for the treatment of patients with relapsed or refractory aggressive Non-Hodgkin’s Lymphoma who have received 2 or

Add to Reading List

Source URL: www.fda.gov

Language: English
36CMYK  N E T W O R K THE NEWSLETTER OF THE INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RESEARCH  Volume 3, Number 4, Spring 2003 — Inside: SPECIAL REPORT—The 2003 Annual

CMYK N E T W O R K THE NEWSLETTER OF THE INTERNATIONAL NETWORK FOR CANCER TREATMENT AND RESEARCH Volume 3, Number 4, Spring 2003 — Inside: SPECIAL REPORT—The 2003 Annual

Add to Reading List

Source URL: www.inctr.org

Language: English - Date: 2010-11-04 15:38:48
372010 NORTH CAROLINA CANCER INCIDENCE BY GENDER PER 100,000 POPULATION AGE-ADJUSTED TO THE 2000 US CENSUS SITE Oral Cavity Esophagus

2010 NORTH CAROLINA CANCER INCIDENCE BY GENDER PER 100,000 POPULATION AGE-ADJUSTED TO THE 2000 US CENSUS SITE Oral Cavity Esophagus

Add to Reading List

Source URL: www.schs.state.nc.us

Language: English - Date: 2012-12-13 14:39:08
382009 NORTH CAROLINA CANCER INCIDENCE BY RACE PER 100,000 POPULATION AGE-ADJUSTED TO THE 2000 US CENSUS SITE Oral Cavity Esophagus

2009 NORTH CAROLINA CANCER INCIDENCE BY RACE PER 100,000 POPULATION AGE-ADJUSTED TO THE 2000 US CENSUS SITE Oral Cavity Esophagus

Add to Reading List

Source URL: www.schs.state.nc.us

Language: English - Date: 2012-01-26 13:41:17
392009 NORTH CAROLINA CANCER INCIDENCE BY GENDER PER 100,000 POPULATION AGE-ADJUSTED TO THE 2000 US CENSUS SITE Oral Cavity Esophagus

2009 NORTH CAROLINA CANCER INCIDENCE BY GENDER PER 100,000 POPULATION AGE-ADJUSTED TO THE 2000 US CENSUS SITE Oral Cavity Esophagus

Add to Reading List

Source URL: www.schs.state.nc.us

Language: English - Date: 2012-01-26 13:41:16
40First Announcement_newsletter.indd

First Announcement_newsletter.indd

Add to Reading List

Source URL: www.inctr.org

Language: English - Date: 2010-11-04 15:08:14